• Explore /
  • Poster
  • / Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer.

Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer.

Abstract Poster

Authors

null

Takuya Miura

Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

Takuya Miura , Eiji Sunami , Tetsuya Kusumoto , Mitsuyoshi Ota , Kazuhiro Yoshida , Naohiro Tomita , Atsuyuki Maeda , Izumi Mochizuki , Michio Okabe , Katsuyuki Kunieda , Junichiro Yamauchi , Michio Itabashi , Kenjiro Kotake , Keiichi Takahashi , Hideo Baba , Narikazu Boku , Keisuke Aiba , Megumi Ishiguro , Satoshi Morita , Kenichi Sugihara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Other Colorectal and Anal Cancer

Clinical Trial Registration Number

JapicCTI-101073

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3622)

DOI

10.1200/JCO.2016.34.15_suppl.3622

Abstract #

3622

Poster Bd #

319

Abstract Disclosures

Similar Posters

First Author: Naohiro Tomita

First Author: Romain Cohen

First Author: Jemma Megan Boyle

First Author: Suganija Lakkunarajah